Abstract:Abstract Background Anemia has been reported as poor prognostic factor on heart failure with preserved ejection fraction (HFpEF) in past reports. However, it is not clear at which level hemoglobin (Hb) should be managed to prevent worsening the prognosis of HFpEF. Aim The aim of this study is to evaluate the impact of the change in Hb from discharge of congestive heart failure to one year after discharge on the prognosis of HFpEF and verify at which level hemoglobin (Hb) should be managed to prevent worsening the prognosis of HFpEF. Method First, 809 HFpEF cases enrolled from June 2016 to June 2021 in PURSUIT-HFpEF registry were divided into three groups according to Hb at discharge, group with Hb < 11 g/dl (n = 327), group with 11 g/dl ≤ Hb < 13 g/dl (n = 300), and group with Hb ≥ 13 g/dl (n = 182). Secondly, the group with Hb < 11 g/dl (n = 327) was divided into two groups according to Hb one year later, group with Hb < 11 g/dl (G1, n = 179) and group with Hb ≥ 11 g/dl (G2, n = 148). Thirdly, the group with 11 g/dl ≤ Hb < 13 g/dl (n = 300) at discharge was divided into three groups according to Hb one year later, group with Hb < 11 g/dl (G3, n = 94), group with 11 g/dl ≤ Hb < 13 g/dl (G4, n = 129), and group with Hb ≥ 13 g/dl (G5, n = 77). Fourthly, the group with Hb ≥ 13 g/dl (n = 182) at discharge was divided into two groups, group with Hb < 13 g/dl (G6, n = 65) and group with Hb ≥ 13 g/dl (G7, n = 117). Major Adverse Cardiovascular Events (MACE) were defined as composite of all-cause death and heart failure readmission. We examined adjusted Hazard ratio (aHR) and incidence rate for MACE between each two groups by Cox regression model and log-rank test. Result MACE and all-cause death were significantly lower in G2 than in G1 (MACE;aHR : 0.71, 95%Confidence Interval (CI) : 0.48 - 1.04, log-rank p = 0.012), all-cause death;aHR : 0.47, 95%CI : 0.27 - 0.82, log-rank p = 0.010). MACE, all-cause death and heart failure readmission were significantly higher in G3 than in G4 (MACE;aHR : 1.69, 95%CI : 1.11 - 2.57, log-rank p = 0.005, all-cause death;aHR : 2.71, 95%CI : 1.37 - 5.40, log-rank p = 0.026, heart failure readmission ; aHR : 1.59, 95% CI : 1.01 - 2.52, log-rank p = 0.006). All-cause death was significantly lower in G5 than in G4 (aHR : 0.20, 95%CI : 0.05 - 0.84, log-rank p = 0.045). All-cause death was significantly higher in G6 than in G7 (aHR : 10.2, 95%CI : 1.13 - 92.5, log-rank p < 0.001). In multivariate Cox regression model, worsening anemia to Hb < 11 g/dl one year later in patients with 11 g/dl ≤ Hb < 13 g/dl at discharge was independent predictor for MACE (HR : 2.02, 95%CI : 1.17 – 3.49, log-rank p = 0.011). Conclusion The impact of post discharge change in hemoglobin seemed to be associated more strongly with all-cause death than heart failure readmission. Hemoglobin levels of at least 11 g/dl might be maintained to prevent the prognosis of HFpEF patients worse after discharge of acute decompensated heart failure.Study flowchart and Forrest plotKaplan-Meier curves and log-rank test

Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020-2022

Impact of hemoglobin on survival of young women with cervical cancer treated with concurrent chemoradiotherapy.

Are outcomes of locally advanced cervical cancer associated with prebrachytherapy hemoglobin values and transfusion practice? An observational study comparing two large academic centres with divergent clinical guidelines

Evaluation of the hemoglobin cutoff point for anemia in adult women residents of different altitudinal levels in Peru

Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy

Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer

Hematological parameters in high altitude residents living at 4,355, 4,660, and 5,500 meters above sea level.

Association of Haemoglobin Level with Morbidity and Mortality of Patients with Locally Advanced Oesophageal Carcinoma Undergoing Radiotherapy--a Secondary Analysis of Three Consecutive Clinical Phase III Trials.

HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.

Prognostic Impact of Hemoglobin Concentration on Long-term Treatment Outcome in Patients with Nasopharyngeal Carcinoma Treated with Radiotherapy

Clinicopathological characteristics and features of molecular subtypes of breast cancer at high altitudes

Serem Ferritin Was the Only Prognostic Factor for Disease Free Survival in Mds Patients after Allo-Hsct: A Single Centre Study

Baseline and dynamic changes in haemoglobin levels predict treatment response and prognosis in metastatic renal cell carcinoma – a multicentre retrospective study

Association between serum concentrations of hypoxia inducible factor responsive proteins and excessive erythrocytosis in high altitude Peru.

Hematological Parameters at Baseline: A Novel Prognostic Factor for Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy in South India

The Influence of Altitude on Erythropoietin Resistance Index in Maintenance Hemodialysis Patients: Data from Tibetan Plateau

Adaptation to Living at High Altitude in Patients with COPD. Comparative Study of Exercise Capacity and Ventilatory Variables between Patients Residing at High and Low Altitudes in the Andes

Inflammatory markers related to survival in breast cancer patients: Peru

Prognostic value of baseline hemoglobin-to-red blood cell distribution width ratio in small cell lung cancer: A retrospective analysis

Preoperative low hematocrit is an adverse prognostic biomarker in ovarian cancer

Validation of the impact of post discharge change in hemoglobin on the prognosis of HFpEF patients after acute decompensated heart failure from PURSUIT-HFpEF registry